The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment Decisions.
作者信息
Behr Juergen, Salisbury Margaret L, Walsh Simon L F, Podolanczuk Anna J, Hariri Lida P, Hunninghake Gary M, Kolb Martin, Ryerson Christopher J, Cottin Vincent, Beasley Mary B, Corte Tamera, Glanville Allan R, Adegunsoye Ayodeji, Hogaboam Cory, Wuyts Wim A, Noth Imre, Oldham Justin M, Richeldi Luca, Raghu Ganesh, Wells Athol U
机构信息
Department of Medicine V, LMU University Hospital, LMU Munich, Comprehensive Pneumology Center, Member of the German Center for Lung Research, Munich, Germany.
Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
出版信息
Am J Respir Crit Care Med. 2024 Aug 15;210(4):392-400. doi: 10.1164/rccm.202401-0048PP.
Abstract
摘要
相似文献
1
The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment Decisions.炎症和纤维化在间质性肺疾病治疗决策中的作用
Am J Respir Crit Care Med. 2024 Aug 15;210(4):392-400. doi: 10.1164/rccm.202401-0048PP.
2
Initiation of antifibrotic treatment in fibrosing interstitial lung disease: is the clock ticking till proven progression?纤维化间质性肺疾病抗纤维化治疗的启动：在证实疾病进展之前，时间是否紧迫？
Eur Respir Rev. 2025 Aug 6;34(177). doi: 10.1183/16000617.0023-2025. Print 2025 Jun.
3
Pulmonary fibrosis: from pathogenesis to clinical decision-making.肺纤维化：从发病机制到临床决策。
Trends Mol Med. 2023 Dec;29(12):1076-1087. doi: 10.1016/j.molmed.2023.08.010. Epub 2023 Sep 14.
4
Pulmonary fibrosis may begin in infancy: from childhood to adult interstitial lung disease.肺纤维化可能始于婴儿期：从儿童到成人的间质性肺疾病。
Thorax. 2024 Nov 14;79(12):1162-1172. doi: 10.1136/thorax-2024-221772.
5
[Perioperative lung injury: acute exacerbation of idiopathic pulmonary fibrosis and acute interstitial pneumonia after pulmonary resection].围手术期肺损伤：肺切除术后特发性肺纤维化急性加重及急性间质性肺炎
Nihon Geka Gakkai Zasshi. 2004 Dec;105(12):757-62.
6
[Target organ the lungs: diversity of fibrotic pulmonary diseases].[目标器官——肺：纤维化肺部疾病的多样性]
Inn Med (Heidelb). 2025 Jun 24. doi: 10.1007/s00108-025-01911-7.
7
FeNO as a biomarker of interstitial and fibrotic pulmonary sequelae in patients admitted for severe SARS-CoV-2 pneumonia.呼出气一氧化氮作为重症新型冠状病毒肺炎患者间质性和纤维化肺部后遗症的生物标志物。
Sci Rep. 2025 Jul 16;15(1):25696. doi: 10.1038/s41598-025-09229-y.
8
Diagnostic and prognostic trajectories of interstitial lung diseases after the multidisciplinary discussion.多学科讨论后间质性肺疾病的诊断和预后轨迹
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251323487. doi: 10.1177/17534666251323487. Epub 2025 Mar 13.
9
Clinical characteristics of non-idiopathic pulmonary fibrosis, progressive fibrosing interstitial lung diseases: A single-center retrospective study.非特发性肺纤维化、进行性纤维性间质性肺疾病的临床特征：一项单中心回顾性研究。
Medicine (Baltimore). 2021 Apr 2;100(13):e25322. doi: 10.1097/MD.0000000000025322.
10
Forced vital capacity reduction severity in pulmonary fibrosis and post-lung transplantation outcomes.肺纤维化中用力肺活量降低的严重程度与肺移植术后结局
Respir Med Res. 2025 May;87:101158. doi: 10.1016/j.resmer.2025.101158. Epub 2025 Jan 25.
引用本文的文献
1
Progressive pulmonary fibrosis: current perspectives in diagnostic imaging.进行性肺纤维化：诊断成像的当前观点
BJR Open. 2025 Jul 24;7(1):tzaf018. doi: 10.1093/bjro/tzaf018. eCollection 2025 Jan.
2
Treating connective tissue disease-associated interstitial lung disease - think outside the box: a perspective.治疗结缔组织病相关间质性肺病——跳出框框思考：一种观点
Eur Respir Rev. 2025 Jul 23;34(177). doi: 10.1183/16000617.0046-2025. Print 2025 Jul.
3
Analysis of the relationship between bronchoalveolar lavage lymphocyte fraction and detailed autoimmune features in patients with idiopathic interstitial pneumonia.特发性间质性肺炎患者支气管肺泡灌洗淋巴细胞分数与详细自身免疫特征之间的关系分析
Sci Rep. 2025 Jul 19;15(1):26295. doi: 10.1038/s41598-025-12180-7.
4
Clinical Insights and Therapeutic Strategies for the Treatment of Interstitial Lung Disease in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Trends and Future Directions.抗中性粒细胞胞浆抗体相关血管炎患者间质性肺疾病治疗的临床见解与治疗策略：当前趋势与未来方向
J Clin Med. 2025 Jun 30;14(13):4631. doi: 10.3390/jcm14134631.
5
Predictive role of inflammatory markers in characterizing the progression of interstitial lung disease: a retrospective analysis.炎症标志物在间质性肺疾病进展特征中的预测作用：一项回顾性分析
Am J Transl Res. 2025 May 15;17(5):3485-3495. doi: 10.62347/JZTW5621. eCollection 2025.
6
Real-life characteristics and management of patients with fibrosing interstitial lung disease: INSIGHTS-ILD registry.纤维化间质性肺疾病患者的真实生活特征与管理：INSIGHTS-ILD注册研究
ERJ Open Res. 2025 Jun 9;11(3). doi: 10.1183/23120541.00926-2024. eCollection 2025 May.
7
Associations of interstitial lung disease subtype and CT pattern with lung function and survival.间质性肺疾病亚型及CT表现与肺功能和生存率的相关性
Thorax. 2025 Jun 8. doi: 10.1136/thorax-2024-222149.
8
Monthly pulse methylprednisolone infusions in patients with non-idiopathic pulmonary fibrosis interstitial lung diseases: a single-center retrospective analyses.非特发性肺纤维化间质性肺疾病患者每月静脉输注甲泼尼龙：一项单中心回顾性分析
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251342661. doi: 10.1177/17534666251342661. Epub 2025 May 30.
9
Connective tissue disease-associated interstitial lung disease: an approach to treatment amidst an expanding evidence base.结缔组织病相关间质性肺疾病：在不断扩充的证据基础上的治疗方法
Intern Med J. 2025 Jun;55(6):885-894. doi: 10.1111/imj.70026. Epub 2025 Mar 7.
10
Tertiary lymphoid structures and B-cell infiltration are IPF features with functional consequences.三级淋巴结构和 B 细胞浸润是特发性肺纤维化的特征，具有功能后果。
Front Immunol. 2024 Oct 11;15:1437767. doi: 10.3389/fimmu.2024.1437767. eCollection 2024.
本文引用的文献
1
Ex vivo tissue perturbations coupled to single-cell RNA-seq reveal multilineage cell circuit dynamics in human lung fibrogenesis.体外组织扰动与单细胞 RNA 测序相结合，揭示了人类肺纤维化形成中的多谱系细胞回路动力学。
Sci Transl Med. 2023 Dec 6;15(725):eadh0908. doi: 10.1126/scitranslmed.adh0908.
2
Spatially distinct molecular patterns of gene expression in idiopathic pulmonary fibrosis.特发性肺纤维化中基因表达的空间分布模式。
Respir Res. 2023 Nov 17;24(1):287. doi: 10.1186/s12931-023-02572-6.
3
Mapping the genetic architecture of idiopathic pulmonary fibrosis: Meta-analysis and epidemiological evidence of case-control studies.特发性肺纤维化的遗传结构图谱：病例对照研究的荟萃分析和流行病学证据。
Gene. 2024 Feb 15;895:147993. doi: 10.1016/j.gene.2023.147993. Epub 2023 Nov 15.
4
Differentiating interstitial lung diseases from other respiratory diseases using electronic nose technology.利用电子鼻技术鉴别间质性肺疾病与其他呼吸系统疾病。
Respir Res. 2023 Nov 6;24(1):271. doi: 10.1186/s12931-023-02575-3.
5
Molecular and Genetic Biomarkers in Idiopathic Pulmonary Fibrosis: Where Are We Now?特发性肺纤维化中的分子和遗传生物标志物：我们目前的进展如何？
Biomedicines. 2023 Oct 16;11(10):2796. doi: 10.3390/biomedicines11102796.
6
Biomarkers in the Pathogenesis, Diagnosis, and Treatment of Systemic Sclerosis.系统性硬化症发病机制、诊断及治疗中的生物标志物
J Inflamm Res. 2023 Oct 17;16:4633-4660. doi: 10.2147/JIR.S379815. eCollection 2023.
7
Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: a EUSTAR database analysis.基于系统性硬化症相关间质性肺病持续性炎症的表型分析：EUSTAR 数据库分析。
Thorax. 2023 Dec;78(12):1188-1196. doi: 10.1136/thorax-2023-220541. Epub 2023 Oct 5.
8
Clinical Application of Confocal Laser Endomircoscopy Combined with Cryobiopsy in the Diagnosis of Interstitial Lung Disease.共聚焦激光显微内镜联合冷冻活检在间质性肺疾病诊断中的临床应用。
Respiration. 2023;102(10):891-898. doi: 10.1159/000533868. Epub 2023 Sep 27.
9
Deep Learning-based Fibrosis Extent on Computed Tomography Predicts Outcome of Fibrosing Interstitial Lung Disease Independent of Visually Assessed Computed Tomography Pattern.基于深度学习的 CT 纤维化程度可预测纤维性间质性肺病的结局，与视觉评估 CT 模式无关。
Ann Am Thorac Soc. 2024 Feb;21(2):218-227. doi: 10.1513/AnnalsATS.202301-084OC.
10
Combination of BAL and Computed Tomography Differentiates Progressive and Non-progressive Fibrotic Lung Diseases.支气管肺泡灌洗术与计算机断层扫描相结合可鉴别进行性和非进行性纤维化性肺病。
Am J Respir Crit Care Med. 2023 Nov 1;208(9):975-982. doi: 10.1164/rccm.202305-0796OC.
Zotero 插件